BRG1 loss can potentially impact cancer development, as a variety of key cellular proteins are SWI/SNF-dependent, such as the transcription factor ZEB1, which regulates E-cadherin and epithelial to mesenchymal transition (EMT) [40, 41]. Here, SMARCA4 is linked to cancer.